Blum A, Shamburek R
Department of Medicine, Baruch Padeh Poria Medical Center, Technion, Lower Galilee, Israel.
Atherosclerosis. 2009 Apr;203(2):325-30. doi: 10.1016/j.atherosclerosis.2008.08.022. Epub 2008 Sep 2.
Statins have been demonstrated to significantly affect the prognosis and outcome of patients with risk factors to atherosclerosis (in primary and secondary prevention trials). Several clinical and recently basic studies have suggested an extra-beneficial effect of the statins in the prevention of atherosclerosis and coronary artery disease. These studies showed that statins may affect the cardiovascular system beyond their effect on the lipid profile, and it was suggested that they affect the immunological system and vascular inflammation. Many of the beneficial pleiotropic effects of statins occur as a result of modulated endothelial function and reduced inflammatory processes. Attempting to understand these properties of statins is an exciting field of research that will also improve our understanding of vascular biology in health and disease, and thus enable the better use of this drug class in clinical practice.
他汀类药物已被证明可显著影响动脉粥样硬化危险因素患者的预后和结局(在一级和二级预防试验中)。多项临床研究以及最近的基础研究表明,他汀类药物在预防动脉粥样硬化和冠状动脉疾病方面具有额外的益处。这些研究表明,他汀类药物对心血管系统的影响可能超出其对血脂水平的作用,有人认为它们会影响免疫系统和血管炎症。他汀类药物许多有益的多效性作用是通过调节内皮功能和减轻炎症过程而产生的。试图了解他汀类药物的这些特性是一个令人兴奋的研究领域,这也将增进我们对健康和疾病状态下血管生物学的理解,从而在临床实践中更好地使用这类药物。